Bioinformatics
BioInformatics is a B2B market research and advisory firm serving life science and diagnostics suppliers, leveraging a proprietary 50,000-expert Science Advisory Board to deliver syndicated reports and custom research to enterprise clients.
- Company typePrivate
- Founded1994
- HeadquartersArlington, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Bioinformatics does
BioInformatics is a B2B market research and advisory firm serving the life science and diagnostics industries, founded in 1994 and headquartered in Arlington, Virginia. The company operates as a brand within Science and Medicine Group, a diversified holding company whose other brands include SDi, Kalorama Information, IMV, Instrument Business Outlook, AuntMinnie, AuntMinnieEurope, and DrBicuspid. Its core asset is the proprietary Science Advisory Board, a network of over 50,000 scientific experts that powers primary research engagements by giving the firm direct access to practicing life science researchers for survey-based intelligence.
The company monetizes through three product lines and eight advisory solutions. Product lines include syndicated Market Reports (priced at $8,000–$10,000 per report, covering annual studies such as Customer Loyalty and Switching: Antibodies, Perceptions of AI in Life Sciences, and Mapping the Modern Life Science Purchasing Journey), Custom Market Research (bespoke engagements addressing specific strategic questions), and Accelerated Insights (expedited research for time-sensitive decisions). Advisory solutions span customer insights, go-to-market strategy, growth opportunities, market landscape, pricing strategy, product development, branding, and competitive assessment. Distribution is direct-to-enterprise via the company website and inside sales, supported by content marketing through a resource hub, webinars featuring staff analysts, and syndicated reports as top- and mid-funnel lead generation.
BioInformatics serves analytical instrumentation companies, drug discovery companies, and life science research organizations, with named enterprise customers including Illumina, Millipore Sigma, Beckman Coulter, and Cytiva. The firm has historically pursued inorganic growth: it acquired IMV Publishing in March 2018 and Kalorama Information in November 2018, supported by approximately $26.2 million in disclosed 2018 financing led by BroadOak Capital Partners, Pablo Capital, and Research Corporation Technologies. Operations are US-domiciled; geographic expansion beyond the Arlington headquarters is not documented in available source material.
Bioinformatics firmographics
Firmographics- Name
- Bioinformatics
- Legal name
- BioInformatics (brand of Science and Medicine Group)
- Website
- https://bioinfoinc.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- BioInformatics is a B2B market research and advisory firm serving life science and diagnostics suppliers, leveraging a proprietary 50,000-expert Science Advisory Board to deliver syndicated reports and custom research to enterprise clients.
- Ownership category
- akta.pro rank
Bioinformatics industry classification
Industry- Product category
- Life Science Market Research Services
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
Keywords
Where Bioinformatics is headquartered
LocationHeadquarters
- HQ city
- Arlington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Bioinformatics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Market Research Reports: Syndicated market reports covering life science research, AI perceptions, customer loyalty, and purchasing behavior. Reports are sold at fixed price points ($8,000-$10,000) to enterprise clients.
- Custom Market Research: Bespoke research engagements tailored to specific client needs including branding, competitive assessment, customer insights, go-to-market strategy, growth opportunities, market landscape, pricing strategy, and product development.
- Accelerated Insights: Expedited research solutions for time-sensitive business decisions, providing faster turnaround on market intelligence.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Standard market reports available at $8,000-$10,000 |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Bioinformatics product offering
Product offeringCore offering
BioInformatics provides syndicated market reports, custom market research engagements, and accelerated insights to life science and diagnostics suppliers. The firm leverages its proprietary Science Advisory Board network of over 50,000 scientific experts to deliver primary research, customer insights, competitive assessments, and strategic advisory across analytical instrumentation, drug discovery, and life science research organizations.
Product overview
BioInformatics is a brand of Science and Medicine Group providing a portfolio of market research products and advisory solutions to the life science and diagnostics industries since 1994. The offering consists of three core market research products (Accelerated Insights for rapid intelligence delivery, Custom Market Research for tailored studies, and Market Reports for syndicated industry analyses) complemented by seven professional advisory solutions (Customer Insights, Go to Market Strategy, Growth Opportunities, Market Landscape, Pricing Strategy, Product Development, Branding, and Competitive Assessment). The company leverages its Science Advisory Board network of over 50,000 scientific experts to transform raw data into strategic clarity for product innovation and market growth.
Differentiator
Problem solved
Functional benefit
Products and services
- Market Reports Syndicated research reports providing deep commercial insights, in-depth market analyses, technology assessments, and customer insights for the life science industry. Priced at $8,000-$10,000 per report.
- Custom Market Research Tailored market research services addressing specific business questions and strategic needs of life science suppliers, covering branding, competitive assessment, customer insights, go-to-market strategy, growth opportunities, market landscape, pricing strategy, and product development.
- Accelerated Insights Expedited market research offering rapid insights delivery for life science and diagnostics companies seeking quick commercial intelligence and time-sensitive business decisions.
- Customer Insights Service for gathering essential customer feedback to drive informed decision-making and business success for life science suppliers.
- Go to Market Strategy Strategic consulting service developing go-to-market tactics supported by thorough market research to engage target audiences effectively.
- Growth Opportunities Market research-driven guidance for navigating market intricacies and identifying growth opportunities for life science clients.
- Market Landscape Strategic intelligence service providing essential insights beyond extrapolated data to enhance market projections and decision-making.
- Pricing Strategy Market research-driven pricing strategy service balancing profitability with perceived customer value.
- Product Development Advisory service leveraging market research insights throughout the product development process to overcome hurdles and stay ahead of competitors.
- Branding Brand perception measurement service helping clients understand and measure intangible brand perceptions across diverse consumer segments for effective positioning.
- Competitive Assessment Strategic intelligence service analyzing competitors' strategies, market positioning, and customer perceptions to identify differentiation opportunities.
Quantifiable outcome
- 443 global life science researchers surveyed for 2026 AI perceptions report
Companies that use Bioinformatics
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Bioinformatics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature1 record
Bioinformatics partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Bioinformatics competitors and assessment
Company assessmentDirect peers
- Instrument Business Outlook (IBO): Sister brand within Science and Medicine Group focused specifically on analytical and life science instrumentation market data—tightly correlated with BioInformatics' instrumentation research portfolio.
- Evaluate (Norstella): Provider of pharma and biotech market intelligence, forecasts, and consensus analytics; offers comparable syndicated and custom research services for life science suppliers as BioInformatics.
- GlobalData: Publicly listed data and analytics firm with dedicated Pharmaceutical and Healthcare verticals offering syndicated reports, company pipelines, and consumer insights directly overlapping BioInformatics' offerings for life science suppliers.
- Citeline (Informa Pharma Intelligence): Pharma-focused market intelligence provider offering syndicated reports, clinical trial data, and forecasting across the life sciences—directly competitive with BioInformatics' drug discovery and diagnostics coverage.
- Kalorama Information: Sister brand under Science and Medicine Group (acquired by Bioinformatics in 2018); publishes market research on in vitro diagnostics, medical devices, and biotech—operates in near-identical market research space.
- SDi (Strategic Directions International): Sister brand within Science and Medicine Group providing market research and advisory for the analytical instrumentation industry—direct overlap with BioInformatics' instrumentation client base.
Broad incumbents
- IDC Health Insights: Dedicated health/life sciences research arm of IDC covering biopharma, diagnostics, and connected health; competes for enterprise-level supplier analytical budgets alongside BioInformatics.
- Frost & Sullivan: Large global market research and advisory firm covering life sciences, healthcare, and dozens of other verticals; competes directly with BioInformatics for life science supplier market intelligence spend with a much broader portfolio.
- Clarivate (DRG / Decision Resources Group): Public analytics firm with DRG providing life sciences market research and forecasting; broader IP and scientific intelligence portfolio creates a wider incumbency around BioInformatics' niche.
Emerging players
- CFS Clinical (formerly CenterWatch / industry intel): Specialized clinical research and life sciences market intelligence provider; smaller niche player with overlapping coverage of life science supplier competitive dynamics similar to BioInformatics' offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Bioinformatics social profiles
Digital presenceBioinformatics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioinformatics leadership team
Management profileNumber of profiles
Profiles1 record
Bioinformatics funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioinformatics M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioinformatics
What does Bioinformatics do?
BioInformatics provides syndicated market reports, custom market research engagements, and accelerated insights to life science and diagnostics suppliers. The firm leverages its proprietary Science Advisory Board network of over 50,000 scientific experts to deliver primary research, customer insights, competitive assessments, and strategic advisory across analytical instrumentation, drug discovery, and life science research organizations.
Is Bioinformatics a public or private company?
Bioinformatics is a private company. It is classified as private equity controlled and is currently operating.
When was Bioinformatics founded?
Bioinformatics was founded in 1994. It employs 51 to 100 people.
Where is Bioinformatics based?
Bioinformatics is headquartered in Arlington, United States, in the North America region.
How does Bioinformatics make money?
Three revenue lines are on record. Market Research Reports are the primary driver. The others are custom Market Research and accelerated Insights.
Who are Bioinformatics's main competitors?
Direct peers on record are Instrument Business Outlook (IBO), Evaluate (Norstella), GlobalData, Citeline (Informa Pharma Intelligence), Kalorama Information and SDi (Strategic Directions International). Broad incumbents are IDC Health Insights, Frost & Sullivan and Clarivate (DRG / Decision Resources Group). CFS Clinical (formerly CenterWatch / industry intel) is listed as an emerging player.
Does Bioinformatics have an API?
No public API is recorded for Bioinformatics.
What industry is Bioinformatics in?
Bioinformatics's product category is Life Science Market Research Services. Its primary akta.pro industry code is HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence. Its NAICS code is 54169 and its SIC code is 8731.